SCHEMBL7367671

SCHEMBL7367671

COC(=O)C(=O)C(O)CCCCCC(=O)Nc1cccc(-c2ccccc2)c1

nearest known ligand 0.61

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 14/20 0.61
HDAC1 Q13547 14/20 0.61
HDAC3 O15379 12/20 0.60
HDAC2 Q92769 12/20 0.60
HDAC4 P56524 11/20 0.60
HDAC7 Q8WUI4 11/20 0.60
HDAC10 Q969S8 11/20 0.60
HDAC11 Q96DB2 11/20 0.60
HDAC8 Q9BY41 11/20 0.60
HDAC9 Q9UKV0 11/20 0.60
HDAC5 Q9UQL6 11/20 0.60
AURKB Q96GD4 1/20 0.47
USP2 O75604 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7398626 0.89 HDAC6 (0.67) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL7368415 0.83 HDAC1 (0.73) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL4581162 0.81 HDAC6 (0.73) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL7363671 0.78 HDAC6 (0.65) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL1067946 0.78 HDAC6 (0.81) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL5278812 0.78 HDAC6 (0.58) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL6037929 0.77 HDAC6 (0.79) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL6037928 0.77 HDAC6 (0.79) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL6386310 0.77 HDAC6 (1.00) HDAC6HDAC1HDAC3HDAC2HDAC4
SCHEMBL6037980 0.77 HDAC6 (0.74) HDAC6HDAC1HDAC3HDAC2HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020177594-A1 Inhibitors of histone deacetylase ABBOTT LABORATORIES 2002-11-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020177594-A1 Inhibitors of histone deacetylase HDAC1, HDAC11, HDAC3 HDAC6 7/4885HDAC1 1/4885HDAC3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.